UMotif is a scalable and engaging patient-centred data capture platform for modern research.
uMotif has raised $25.2M in total funding. The most recent round was Series B. The last funding was announced in May 2022.
uMotif's investors include AlbionVC, Athyrium Capital Management LP, DNV GL, SBRI Healthcare.
uMotif is headquartered in London, United Kingdom.
UMotif is a scalable and engaging patient-centred data capture platform for modern research.
uMotif is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"uMotif — Funding & Investors." VCBacked, May 25, 2022, https://www.vcbacked.co/company/umotif. Accessed August 14, 2026.
VCBacked. (2022). uMotif — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/umotif
{{cite web |title=uMotif — Funding & Investors |url=https://www.vcbacked.co/company/umotif |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated